1-1 of 1
Authors: Leena Juurinen
Journal Article
Rosiglitazone Reduces Liver Fat and Insulin Requirements and Improves Hepatic Insulin Sensitivity and Glycemic Control in Patients with Type 2 Diabetes Requiring High Insulin Doses Get access
The Journal of Clinical Endocrinology & Metabolism, Volume 93, Issue 1, 1 January 2008, Pages 118–124, https://doi.org/10.1210/jc.2007-1825
Published: 01 January 2008
